• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A bright approach to the immunoproteasome: development of LMP2/β1i-specific imaging probes.一种针对免疫蛋白酶体的新方法:LMP2/β1i 特异性成像探针的开发。
Bioorg Med Chem. 2012 Jan 15;20(2):607-13. doi: 10.1016/j.bmc.2011.06.039. Epub 2011 Jul 7.
2
PSMB9 codon 60 polymorphisms have no impact on the activity of the immunoproteasome catalytic subunit B1i expressed in multiple types of solid cancer.PSMB9 密码子 60 多态性对多种实体瘤中表达的免疫蛋白酶体催化亚基 B1i 的活性没有影响。
PLoS One. 2013 Sep 9;8(9):e73732. doi: 10.1371/journal.pone.0073732. eCollection 2013.
3
Molecular basis of the selectivity of the immunoproteasome catalytic subunit LMP2-specific inhibitor revealed by molecular modeling and dynamics simulations.通过分子建模和动力学模拟揭示免疫蛋白酶体催化亚基 LMP2 特异性抑制剂选择性的分子基础。
J Phys Chem B. 2010 Sep 30;114(38):12333-9. doi: 10.1021/jp1058098.
4
LMP2-specific inhibitors: chemical genetic tools for proteasome biology.LMP2特异性抑制剂:用于蛋白酶体生物学研究的化学遗传学工具。
Chem Biol. 2007 Apr;14(4):419-30. doi: 10.1016/j.chembiol.2007.03.008.
5
Development and characterization of human constitutive proteasome and immunoproteasome subunit-specific monoclonal antibodies.人组成型蛋白酶体和免疫蛋白酶体亚基特异性单克隆抗体的开发与特性分析
Tissue Antigens. 2005 Sep;66(3):185-94. doi: 10.1111/j.1399-0039.2005.00462.x.
6
Optimization of α-amido boronic acids via cryo-electron microscopy analysis: Discovery of a novel highly selective immunoproteasome subunit LMP7 (β5i)/LMP2 (β1i) dual inhibitor.通过冷冻电子显微镜分析优化α-酰胺基硼酸:发现一种新型高选择性免疫蛋白酶体亚基LMP7(β5i)/LMP2(β1i)双重抑制剂。
Bioorg Med Chem. 2024 Jul 15;109:117790. doi: 10.1016/j.bmc.2024.117790. Epub 2024 Jun 12.
7
Immunoproteasome subunit LMP2 expression is deregulated in Sjogren's syndrome but not in other autoimmune disorders.免疫蛋白酶体亚基LMP2的表达在干燥综合征中失调,但在其他自身免疫性疾病中未出现这种情况。
Ann Rheum Dis. 2006 Aug;65(8):1021-7. doi: 10.1136/ard.2005.045930. Epub 2006 Jan 13.
8
LMP2 immunoproteasome promotes lymphocyte survival by degrading apoptotic BH3-only proteins.LMP2 免疫蛋白酶体通过降解凋亡 BH3 仅蛋白促进淋巴细胞存活。
Immunol Cell Biol. 2018 Oct;96(9):981-993. doi: 10.1111/imcb.12163. Epub 2018 Jun 3.
9
Sequence information within proteasomal prosequences mediates efficient integration of beta-subunits into the 20 S proteasome complex.蛋白酶体前序列中的序列信息介导β亚基有效整合到20S蛋白酶体复合物中。
J Mol Biol. 1999 Apr 23;288(1):117-28. doi: 10.1006/jmbi.1999.2660.
10
A structural model of 20S immunoproteasomes: effect of LMP2 codon 60 polymorphism on expression, activity, intracellular localisation and insight into the regulatory mechanisms.20S免疫蛋白酶体的结构模型:LMP2密码子60多态性对表达、活性、细胞内定位的影响及对调控机制的深入了解
Biol Chem. 2006 Apr;387(4):417-29. doi: 10.1515/BC.2006.056.

引用本文的文献

1
Imaging antigen processing and presentation in cancer.癌症中成像抗原加工与呈递
Immunother Adv. 2025 Feb 4;5(1):ltaf002. doi: 10.1093/immadv/ltaf002. eCollection 2025.
2
Identification of a new class of proteasome inhibitors based on a naphthyl-azotricyclic-urea-phenyl scaffold.基于萘基-氮杂三环-脲-苯基支架鉴定一类新型蛋白酶体抑制剂。
RSC Med Chem. 2023 Feb 6;14(3):573-582. doi: 10.1039/d2md00404f. eCollection 2023 Mar 22.
3
Site-Specific Proteasome Inhibitors.靶向蛋白酶体抑制剂。
Biomolecules. 2021 Dec 31;12(1):54. doi: 10.3390/biom12010054.
4
Emerging role of immunoproteasomes in pathophysiology.免疫蛋白酶体在病理生理学中的新作用。
Immunol Cell Biol. 2016 Oct;94(9):812-820. doi: 10.1038/icb.2016.50. Epub 2016 Jun 14.
5
Elucidating the catalytic subunit composition of distinct proteasome subtypes: a crosslinking approach employing bifunctional activity-based probes.阐明不同蛋白酶体亚型的催化亚基组成:一种采用基于双功能活性探针的交联方法。
Chembiochem. 2015 Jan 19;16(2):284-92. doi: 10.1002/cbic.201402491. Epub 2014 Dec 4.
6
A FRET-based approach for identification of proteasome catalytic subunit composition.一种基于荧光共振能量转移的蛋白酶体催化亚基组成鉴定方法。
Mol Biosyst. 2014 Feb;10(2):196-200. doi: 10.1039/c3mb70471h.
7
Activity-based imaging probes of the proteasome.基于活性的蛋白酶体成像探针。
Cell Biochem Biophys. 2013 Sep;67(1):91-101. doi: 10.1007/s12013-013-9626-4.
8
Inhibitors of the immunoproteasome: current status and future directions.免疫蛋白酶体抑制剂:现状与未来方向。
Curr Pharm Des. 2013;19(22):4140-51. doi: 10.2174/1381612811319220018.
9
Activity-based near-infrared fluorescent probe for LMP7: a chemical proteomics tool for the immunoproteasome in living cells.基于活性的 LMP7 近红外荧光探针:活细胞中免疫蛋白酶体的化学蛋白质组学工具。
Chembiochem. 2012 Sep 3;13(13):1899-903. doi: 10.1002/cbic.201200307. Epub 2012 Jul 17.

本文引用的文献

1
Molecular basis of the selectivity of the immunoproteasome catalytic subunit LMP2-specific inhibitor revealed by molecular modeling and dynamics simulations.通过分子建模和动力学模拟揭示免疫蛋白酶体催化亚基 LMP2 特异性抑制剂选择性的分子基础。
J Phys Chem B. 2010 Sep 30;114(38):12333-9. doi: 10.1021/jp1058098.
2
Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress.免疫蛋白酶体在干扰素诱导的氧化应激下维持蛋白质平衡。
Cell. 2010 Aug 20;142(4):613-24. doi: 10.1016/j.cell.2010.07.036.
3
Activity-based protein profiling for biochemical pathway discovery in cancer.基于活性的蛋白质谱分析在癌症生化途径发现中的应用。
Nat Rev Cancer. 2010 Sep;10(9):630-8. doi: 10.1038/nrc2901. Epub 2010 Aug 12.
4
Design, synthesis and biological application of chemical probes for bio-imaging.化学探针的设计、合成及生物成像应用。
Chem Soc Rev. 2010 Jun;39(6):2048-53. doi: 10.1039/b819316a. Epub 2010 Apr 6.
5
Proteasomes in immune cells: more than peptide producers?免疫细胞中的蛋白酶体:不仅仅是肽类产物?
Nat Rev Immunol. 2010 Jan;10(1):73-8. doi: 10.1038/nri2687. Epub 2009 Dec 11.
6
Catalytic mechanism and assembly of the proteasome.蛋白酶体的催化机制与组装
Chem Rev. 2009 Apr;109(4):1509-36. doi: 10.1021/cr8004857.
7
Targeted inhibition of the immunoproteasome is a potent strategy against models of multiple myeloma that overcomes resistance to conventional drugs and nonspecific proteasome inhibitors.对免疫蛋白酶体的靶向抑制是一种针对多发性骨髓瘤模型的有效策略,可克服对传统药物和非特异性蛋白酶体抑制剂的耐药性。
Blood. 2009 May 7;113(19):4667-76. doi: 10.1182/blood-2008-07-171637. Epub 2008 Dec 2.
8
The ubiquitin system, disease, and drug discovery.泛素系统、疾病与药物发现。
BMC Biochem. 2008 Oct 21;9 Suppl 1(Suppl 1):S7. doi: 10.1186/1471-2091-9-S1-S7.
9
Chemical biology approaches to probe the proteome.用于探测蛋白质组的化学生物学方法。
Chembiochem. 2008 Dec 15;9(18):2913-9. doi: 10.1002/cbic.200800454.
10
Activity-based protein profiling: from enzyme chemistry to proteomic chemistry.基于活性的蛋白质谱分析:从酶化学到蛋白质组化学
Annu Rev Biochem. 2008;77:383-414. doi: 10.1146/annurev.biochem.75.101304.124125.

一种针对免疫蛋白酶体的新方法:LMP2/β1i 特异性成像探针的开发。

A bright approach to the immunoproteasome: development of LMP2/β1i-specific imaging probes.

机构信息

Department of Pharmaceutical Science, College of Pharmacy, University of Kentucky, Lexington, KY 40536, USA.

出版信息

Bioorg Med Chem. 2012 Jan 15;20(2):607-13. doi: 10.1016/j.bmc.2011.06.039. Epub 2011 Jul 7.

DOI:10.1016/j.bmc.2011.06.039
PMID:21741845
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3193892/
Abstract

While the constitutive, 26S proteasome plays an important role in regulating many important cellular processes, a variant form known as the immunoproteasome is thought to primarily function in adaptive immune responses. However, recent studies indicate an association of immunoproteasomes with many physiological disorders such as cancer, neurodegenerative, and inflammatory diseases. Despite this, the detailed functions of the immunoproteasome remain poorly understood. Immunoproteasome-specific probes are essential to gain insight into immunoproteasome function. Here, we describe for the first time the development of cell-permeable activity-based fluorescent probes, UK101-Fluor and UK101-B660, which selectively target the catalytically active LMP2/β1i subunit of the immunoproteasome. These probes facilitate rapid detection of the cellular localization of catalytically active immunoproteasomes in living cells, providing a valuable tool to analyze immunoproteasome functions. Additionally, as LMP2/β1i may serve as a potential tumor biomarker, an LMP2/β1i-targeting fluorescent imaging probe may be applicable to a rapid readout assay to determine tumor LMP2/β1i levels.

摘要

尽管组成型的 26S 蛋白酶体在调节许多重要的细胞过程中发挥着重要作用,但一种被称为免疫蛋白酶体的变体形式被认为主要在适应性免疫反应中发挥作用。然而,最近的研究表明,免疫蛋白酶体与许多生理紊乱有关,如癌症、神经退行性和炎症性疾病。尽管如此,免疫蛋白酶体的详细功能仍知之甚少。免疫蛋白酶体特异性探针对于深入了解免疫蛋白酶体功能至关重要。在这里,我们首次描述了细胞通透性的基于活性的荧光探针 UK101-Fluor 和 UK101-B660 的开发,它们选择性地针对免疫蛋白酶体的催化活性 LMP2/β1i 亚基。这些探针有助于在活细胞中快速检测催化活性免疫蛋白酶体的细胞定位,为分析免疫蛋白酶体功能提供了有价值的工具。此外,由于 LMP2/β1i 可作为潜在的肿瘤生物标志物,因此针对 LMP2/β1i 的荧光成像探针可用于快速读出测定来确定肿瘤 LMP2/β1i 水平。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b9b/3193892/f92e3ee3263b/nihms306690f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b9b/3193892/17a07f0f80e5/nihms306690f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b9b/3193892/1f3fff51f356/nihms306690f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b9b/3193892/802e9d5a6704/nihms306690f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b9b/3193892/6744a21418c4/nihms306690f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b9b/3193892/35867fabea16/nihms306690f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b9b/3193892/dd871339678a/nihms306690f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b9b/3193892/f92e3ee3263b/nihms306690f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b9b/3193892/17a07f0f80e5/nihms306690f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b9b/3193892/1f3fff51f356/nihms306690f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b9b/3193892/802e9d5a6704/nihms306690f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b9b/3193892/6744a21418c4/nihms306690f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b9b/3193892/35867fabea16/nihms306690f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b9b/3193892/dd871339678a/nihms306690f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b9b/3193892/f92e3ee3263b/nihms306690f7.jpg